{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:10:57Z","timestamp":1768590657562,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The objective of this study is to clarify the clinical features of thyroid dysfunction observed in patients with autoimmune pancreatitis (AIP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We repeatedly examined thyroid function in 74 patients with type 1 AIP (58 males, 16 females; average onset age of AIP 67\u2005years). Clinical and serological findings in patients with thyroid dysfunction were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During follow-up, clinical and subclinical hypothyroidism were observed in 3 and 17 patients, respectively. Clinical and subclinical hyperthyroidism were observed in 5 and 1 patients, respectively. One patient showed clinical hyperthyroidism followed by subclinical hypothyroidism. All patients with clinical and subclinical hypothyroidism were asymptomatic and required no medical treatment, whereas four patients with clinical hyperthyroidism were symptomatic and received treatment with thiamazole.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Frequent hypothyroidism in AIP, which was previously reported, was confirmed. Moreover, in this study, the association between hyperthyroidism and AIP was demonstrated. Hyperthyroidism in AIP may be more clinically significant than hypothyroidism because patients frequently require medical treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002846","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:05:19Z","timestamp":1727345119000},"page":"1399-1403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Hyperthyroidism and hypothyroidism in patients with autoimmune pancreatitis"],"prefix":"10.1097","volume":"36","author":[{"given":"Kenji","family":"Hirano","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital"},{"name":"Department of Gastroenterology, Tokyo Teishin Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Sanga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Natomi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Niwa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease.","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5009\/gnl.2013.7.4.394","article-title":"Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea.","volume":"7","author":"Kamisawa","year":"2013","journal-title":"Gut Liver"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.EJ20-0557","article-title":"Proposal of diagnostic criteria for IgG4-related thyroid disease.","volume":"68","author":"Takeshima","year":"2021","journal-title":"Endocr J"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03009742.2012.761281","article-title":"Clinical features of a new disease concept, IgG4-related thyroiditis.","volume":"42","author":"Watanabe","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12020-013-9988-9","article-title":"Serum levels of IgG and IgG4 in Hashimoto thyroiditis.","volume":"45","author":"Kawashima","year":"2014","journal-title":"Endocrine"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ15-0157","article-title":"Distribution of serum immunoglobulin G4 levels in Hashimoto\u2019s thyroiditis and clinical features of Hashimoto\u2019s thyroiditis with elevated serum immunoglobulin G4 levels.","volume":"62","author":"Takeshima","year":"2015","journal-title":"Endocr J"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/thy.2013.0448","article-title":"Elevated serum immunoglobulin G4 levels in patients with Graves\u2019 disease and their clinical implications.","volume":"24","author":"Takeshima","year":"2014","journal-title":"Thyroid"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/cen.12671","article-title":"Serum immunoglobulin G4 levels are elevated in patients with Graves\u2019 ophthalmopathy.","volume":"83","author":"Bozkirli","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-20250801","first-page":"325","article-title":"Serum total IgG and IgG4 levels in thyroid eye disease.","volume":"9","author":"Sy","year":"2016","journal-title":"Int Med Case Rep J"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.56.7824","article-title":"Clinical features of patients with Basedow\u2019s disease and high serum IgG4 levels.","volume":"56","author":"Torimoto","year":"2017","journal-title":"Intern Med"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/thy.2017.0126","article-title":"Clinical implications of immunoglobulin G4 to Graves\u2019 ophthalmopathy.","volume":"27","author":"Yu","year":"2017","journal-title":"Thyroid"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/a-0669-9333","article-title":"Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves\u2019 disease.","volume":"128","author":"Hiratsuka","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/09273948.2020.1826537","article-title":"Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves\u2019 ophthalmopathy patients.","volume":"30","author":"Luo","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s10620-005-2703-9","article-title":"High prevalence of hypothyroidism in patients with autoimmune pancreatitis.","volume":"50","author":"Komatsu","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/MPA.0b013e3181e2188a","article-title":"Clinical hypothyroidism in autoimmune pancreatitis.","volume":"39","author":"Sah","year":"2010","journal-title":"Pancreas"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4292\/wjgpt.v9.i2.16","article-title":"Hypothyroidism in patients with autoimmune pancreatitis.","volume":"9","author":"Shimizuguchi","year":"2018","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2012.68","article-title":"Distinct histopathological features of Hashimoto\u2019s thyroiditis with respect to IgG4-related disease.","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort.","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MPA.0000000000001007","article-title":"Relative rise of serum IgG4 levels after steroid therapy for autoimmune pancreatitis predicts the likelihood of relapse.","volume":"47","author":"Suzuki","year":"2018","journal-title":"Pancreas"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MCG.0000000000000440","article-title":"Outcome of long-term maintenance steroid therapy cessation in patients with autoimmune pancreatitis: a prospective study.","volume":"50","author":"Hirano","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/MPA.0b013e3182156e32","article-title":"Significance of measuring IgG and IgG4 during follow-up of autoimmune pancreatitis.","volume":"40","author":"Hirano","year":"2011","journal-title":"Pancreas"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00535-016-1302-1","article-title":"Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.","volume":"52","author":"Kubota","year":"2017","journal-title":"J Gastroenterol"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"651534","DOI":"10.3389\/fendo.2021.651534","article-title":"Hyperthyroidism prevalence in China after universal salt iodization.","volume":"28","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R30-20250801","first-page":"9","article-title":"Update on autoimmune polyendocrine syndromes (APS).","volume":"74","author":"Betterle","year":"2003","journal-title":"Acta Biomed"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2019.1710766","article-title":"Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study.","volume":"55","author":"Zeng","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40618-022-01994-1","article-title":"Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.","volume":"46","author":"Betterle","year":"2023","journal-title":"J Endocrinol Invest"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T17:01:22Z","timestamp":1754067682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002846","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}